Over 2.9k drugs found to be substandard in tests conducted in 2022-23: Govt

The government is now trying to understand how long it will take before the drug’s production can start in India

In a written reply, Minister of State for Health Bharati Pravin Pawar said 642 prosecutions were launched for manufacturing, sale and distribution of spurious/adulterated drugs, while 262 persons were arrested during the same period as per information received from drugs controllers of various states and Union territories.


Out of the 89,729 drug samples tested between April 2022 and March 2023, 2,921 drugs were found to be “not of standard quality” while 422 were identified as spurious, the Rajya Sabha was told on Tuesday.


In a written reply, Minister of State for Health Bharati Pravin Pawar said 642 prosecutions were launched for manufacturing, sale and distribution of spurious/adulterated drugs, while 262 persons were arrested during the same period as per information received from drugs controllers of various states and Union territories.


This excludes data from Rajasthan.


Giving details of the previous year, Pawar said a total 88,844 samples were tested between April 2021 and March 2022 of which 2,545 were declared to be not of standard quality while 379 were found to be spurious.


She said 592 prosecutions were launched for manufacturing, sale and distribution of spurious/adulterated drugs and 450 persons arrested during the same period.


Responding to a question, Pawar said that in order to assess the regulatory compliance of drug manufacturing premises in the country, the Central Drugs Standard Control Organization (CDSCO) along with State Drugs Controllers (SDCs) have conducted risk-based inspections of 261 premises.


The firms have been identified based on risk criteria like number of drugs declared as ‘Not of Standard Quality’, complaints, criticality of the products, etc. Based on findings of inspections, more than 200 actions like issuance of show cause notices, stop production order, suspension, cancellation of licences /product licences etc., have been taken by the State Licensing Authorities as per the provisions of the Drugs Rules 1945, the minister stated.

First Published: Dec 19 2023 | 6:55 PM IST

According to a statement made by Minister of State for Health Bharati Pravin Pawar, out of the 89,729 drug samples tested between April 2022 and March 2023, 2,921 drugs were found to be “not of standard quality” and 422 were identified as spurious. The government launched 642 prosecutions and arrested 262 individuals for manufacturing, sale, and distribution of spurious or adulterated drugs during the same period. These figures exclude data from Rajasthan.

In the previous year, between April 2021 and March 2022, a total of 88,844 samples were tested, out of which 2,545 were declared to be not of standard quality and 379 were found to be spurious. During this period, 592 prosecutions were launched and 450 individuals were arrested for manufacturing, sale, and distribution of spurious or adulterated drugs.

To assess the regulatory compliance of drug manufacturing premises in the country, the Central Drugs Standard Control Organization (CDSCO) and State Drugs Controllers (SDCs) conducted risk-based inspections of 261 premises. Based on the findings, more than 200 actions, such as show cause notices, stop production orders, and license suspensions or cancellations, were taken by the State Licensing Authorities.

In a related report titled “Over 2.9k drugs found to be substandard in tests conducted in 2022-23: Govt,” it highlights the alarming number of drugs that were found to be of substandard quality. The government’s efforts to prosecute and arrest individuals involved in the manufacturing and distribution of spurious drugs aim to safeguard public health and ensure the quality of medications available in the market.

To ensure the originality and uniqueness of the content, it is recommended to use proper citations and references when summarizing the provided information. Additionally, utilizing higher perplexity in language generation models can enhance the originality of the text.

Leave a Reply

Your email address will not be published. Required fields are marked *